Ethics Approval

DXB kidney disease treatment Phase III trial officially begins

Finfeed Oct 21, 2021

Today DXB announced that the ethics approval was granted for its Phase III clinical trial on kidney disease FSGS, marking the “official start” of the trial.

DXB kicks off Phase 3 clinical trials - Ethics approval lodged

Finfeed Aug 26, 2021

Yesterday Dimerix (ASX:DXB) announced its first “ethics submission” in Australia. Once approved, the patient recruitment process can begin for the Phase 3 trials. We will provide our commentary at every step in the process.